Olivier Schwartz

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

David E. Gordon, Gwendolyn Μ. Jang, Mehdi Bouhaddou et al. · Nature · 2020 · 4.9K citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Paul Bastard, Lindsey B. Rosen, Qian Zhang et al. · Science · 2020 · 2.8K citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas, David Veyer, Artem Baidaliuk et al. · Nature · 2021 · 2.2K citations · Full text

Pharmacy, Immunology, Infectious Diseases +12

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

Estelle Oberlin, Ali Amara, Françoise Bachelerie et al. · Nature · 1996 · 1.7K citations

Life Sciences, Immunology, Molecular Biology +13

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Delphine Planas, Nell Saunders, Piet Maes et al. · Nature · 2021 · 1.6K citations · Full text

Pharmacy, Immunology, Infectious Diseases +14